Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA Supplementation in Pregnant Women With Hypertension
NCT02137408Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Dec 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of docosahexaenoic acid in gestational hypertension (GH) (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Improve maternal endothelial health. Planned start Dec 2014; status: withdrawn.
02
Drugs
docosahexaenoic acid
03
Conditions
gestational hypertension (GH)
Beyond the preview
Go deeper on NCT02137408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137408.